RESUMO
The action of bright light (2600-2800 lux) on the catecholamine (CA) excretion was analyzed in patients with anxious (11) and melancholic (12) depressions resultant from manic-depressive psychosis and schizophrenia. The melancholic depressed patients were characterized by decreased noradrenaline (NA) and increased adrenaline (A) levels; in anxious depression NA and A were increased. The light therapy resulted in decrease of A level but NA level remained invariable in melancholic depression. Meanwhile the tendency to normalization of excretion of both CA was observed in anxious patients after light therapy. The contrary alterations in A/NA ratio as well as its considerable individual fluctuations were observed after light therapy. The A/NA ratio after light therapy depended mainly upon the initial A/NA ratio (the higher or lower ratio compared to control value).
Assuntos
Transtorno Depressivo/terapia , Transtorno Depressivo/urina , Epinefrina/efeitos da radiação , Epinefrina/urina , Norepinefrina/efeitos da radiação , Norepinefrina/urina , Fototerapia , Adulto , Transtornos de Ansiedade/terapia , Transtornos de Ansiedade/urina , Doença Crônica , Estudos de Avaliação como Assunto , Humanos , Transtornos Psicóticos/terapia , Transtornos Psicóticos/urinaRESUMO
The effects of 1 and 10 bright light exposures (2600-8000 lux) on melatonin excretion in patients with melancholic and anxious depressions were examined. Before treatment the increased basic levels of melatonin excretion were observed in patients with anxious depression. Melatonin excretion had been gradually normalized after 1 and 10 sessions of light therapy. The basic melatonin excretion in melancholic depressed patients was low and hadn't been changed after light therapy. Long term effects of light therapy depend upon the initial levels of melatonin excretion: low pretreatment levels increased and high pretreatment levels decreased after the therapy. The authors proposed that bright light exposures stimulated the restoration of adaptive function of pineal gland in depressed patients.
Assuntos
Transtorno Depressivo Maior/terapia , Transtorno Depressivo Maior/urina , Melatonina/efeitos da radiação , Melatonina/urina , Fototerapia/métodos , Adolescente , Adulto , Transtorno Bipolar/terapia , Transtorno Bipolar/urina , Doença Crônica , Feminino , Fluorometria , Humanos , Fototerapia/instrumentação , Esquizofrenia/terapia , Esquizofrenia/urinaRESUMO
Craniocerebral hypothermia was employed in multimodality treatment of 10 patients with hypertoxic schizophrenia and 60 patients with intoxication psychoses, the clinical picture of which was characterized by increasing hypoxia and edema-swelling of the brain. Hypothermia was made to a cerebral temperature of 28-30 degrees C for 4-6 hours in the presence of the neurovegetative blockade. The data obtained attest to a high therapeutic efficacy of craniocerebral hypothermia.
Assuntos
Temperatura Corporal/fisiologia , Encéfalo/fisiopatologia , Hipotermia Induzida/métodos , Psicoses Alcoólicas/terapia , Ressuscitação/métodos , Esquizofrenia Catatônica/terapia , Adulto , Cuidados Críticos/métodos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Psicoses Alcoólicas/fisiopatologia , Esquizofrenia Catatônica/fisiopatologiaRESUMO
A study of singular doses and subsequent maintenance therapy by azafen on the higher nervous activity of mental patients in presenile age (67 cases) revealed that its action depends upon the dosage of the preparation and the nosological syndrome. A depressive involutional psychoses can be controlled by azafen in doses up to 75 mg daily. By dosages of 25 mg azafen reduces or cessates completely the syndrome of changed consciousness due to disorders of brain circulation. An arrest of a depressive syndrome in manic-depressive psychosis in old age can be attained by an introduction of 150-200 mg of azafen daily.